Precision follow-up study for osteoporosis treatment
Treatments studied
Part of Bones, joints & muscles, Hormones & metabolism clinical trials.
This study is a follow-up for people who completed a previous precision medicine trial for osteoporosis. It will monitor your bone health to see how well the treatment is working over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with osteoporosis (a bone-thinning condition) based on a DXA scan with a T-score of -2.5 or lower, with or without a history of broken bones from minor falls.
- You were in the previous 'Novel precision medicine approach to treatment of osteoporosis' trial and finished the therapy part.
- You are a woman who is premenopausal, menopausal, or postmenopausal, and you are 45 years or older.
- Your Vitamin D levels are normal (at least 20 ng/mL).
- You do not have any of the listed health conditions or situations that would exclude you, such as pregnancy, blood thinners, recent cancer history, or certain other bone diseases.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new version of a medicine called abaloparatide (used for bone health) to see if it works the same as the approved version (Tymlos). It is for healthy adults aged 40–65 who are willing to stay at the clinic for a few days and have blood tests.
This study aims to help adults over 50 who had a recent bone fracture (from a minor fall) get better follow-up care to prevent future fractures. You will work with a nurse or coordinator to connect with your primary care doctor and learn about bone health options.
This trial studies AGN1 LOEP, a treatment being tested to improve bone strength in people with osteoporosis-related bone loss in the hip. If you qualify, you would be followed over time with clinic visits and testing to see how the treatment affects your bone health.
This study looks at how the natural aging of the body might affect how well bone-strengthening medications work for osteoporosis. If you are about to start one of these medications, the study will track your bone density over time to see how your response may differ based on your 'biological age.'
This study follows people who have had a minor bone break but whose bone density is not in the osteoporosis range. It aims to learn more about bone health in this group, which may help doctors better prevent future fractures.
This study looks at ways to prevent and treat “brittle bone” refractures after a recent fracture in people with osteoporosis. If you’ve had a new hip, spine, or other bone fracture, the trial may test strategies to lower the chance of another fracture.
Hear when a new Osteoporosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.